Funding awarded
- Robust Statistical Methods for Longitudinal Microbiome Studies awarded by National Institute of General Medical Sciences Principal Investigator 2024 - 2029
- Progression Subtyping and Drug Target Identification for Parkinson''s Disease with Integrative Machine Learning awarded by National Institute of Neurological Disorders & Stroke Co-Investigator 2024 - 2029
- Microbial Biomarkers for Diagnosing and Predicting Infections in Kidney Transplant Recipients awarded by National Institute of Allergy & Infectious Diseases Co-Investigator 2024 - 2029
- Gut microbial beta-glucuronidases as a biomarker for mycophenolic acid enterohepatic recirculation and associated toxicities awarded by National Institute of Diabetes & Digestive & Kidney Diseases Co-Investigator 2024 - 2029
- Data-Driven Approach to Identify Determinants of Outcomes and Risk Factors of Cardiovascular Diseases in New York City Area awarded by Novartis Foundation Co-Investigator 2023 - 2027
- Pre-malignant mutation landscape and risk factors for progression to hematologic cancers awarded by National Cancer Institute Co-Investigator 2021 - 2026
- Characterizing and Predicting Patient Trajectories After Live Discharge from Hospice among Older Adults with Alzheimer''s Disease and Related Dementias awarded by National Institute on Aging Co-Investigator 2024 - 2025
- Statistical Methods for Enhanced Mapping of Microbiome Relationships awarded by National Institute of General Medical Sciences Principal Investigator Subaward 2023 - 2027
- Novel, automated mobile heart rhythm analysis technology to start antiarrhythmic medications safely at home awarded by National Heart, Lung, & Blood Institute Principal Investigator Subaward 2025 - 2026